What companies are RARE's competitors?

Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does RARE compare to its peers?

The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does RARE operate in?

Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQ·Biotechnology · Healthcare

$14.30$0.10−0.69%

Market cap$1.41B·Market closed·Sep 11 8:00 PM UTC

Frequently Asked Questions About RARE

What companies are RARE's competitors?: Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RARE compare to its peers?: The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RARE operate in?: Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQ·Biotechnology · Healthcare

$14.30$0.10−0.69%

Market cap$1.41B·Market closed·Sep 11 8:00 PM UTC

Peers


APGE	Apogee Therapeutics, Inc.	$135.07	$8.4B
CGON	CG Oncology Inc.	$72.35	$6.4B
CNTA	Centessa Pharmaceuticals plc	$40.50	$6.3B
TVTX	Travere Therapeutics, Inc.	$66.17	$6.2B
XENE	Xenon Pharmaceuticals Inc.	$58.65	$5.7B
CELC	Celcuity Inc.	$83.45	$4.1B
IDYA	IDEAYA Biosciences, Inc.	$37.59	$3.6B
DYN	Dyne Therapeutics, Inc.	$18.21	$3.4B
SLNO	Soleno Therapeutics, Inc.	$53.01	$2.8B
AAPG	Ascentage Pharma Group International	$16.10	$1.5B

Frequently Asked Questions About RARE

What companies are RARE's competitors?: Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RARE compare to its peers?: The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RARE operate in?: Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.